Clin Mol Hepatol.
2023 Oct;29(4):1043-1045. 10.3350/cmh.2023.0204.
Letter regarding “Evidence-based hyponatremia management in liver disease”
- Affiliations
-
- 1Department of Radiology, General Hospital of Ioannina, Greece
- 2Department of Radiology, University Hospital of Ioannina, Greece
- 3Department of Internal Medicine, Gastroentology Unit, General Hospital of Ioannina, Ioannina, Greece
- KMID: 2546390
- DOI: http://doi.org/10.3350/cmh.2023.0204
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
- Evidence-based hyponatremia management in liver disease
- Characteristics of Severe Hyponatremia in Hospitalized Patients; A Comparison according to the Presence of Liver Disease
- Hyponatremia in Liver Cirrhosis
- V2 Receptor Antagonist; Tolvaptan
